Syndemics and HIV: Unraveling the Complex Web of Health Inequities
Since the earliest days of the HIV/AIDS pandemic, marginalized populations, and most especially racial and ethnic minority groups, have been
Since the earliest days of the HIV/AIDS pandemic, marginalized populations, and most especially racial and ethnic minority groups, have been
On January 29, 2025, Secretary of State Marco Rubio approved an “Emergency Humanitarian Waiver” to allow the President’s Emergency Plan
Origins of HIV/AIDS Syndemic Theory Syndemics arise when two or more clusters of epidemics occur within a population as a
“It’s the government’s way of controlling people,” remarked one patient with HIV when asked about his interest in restarting antiretroviral
Fear, uncertainty, stress, and anger. Disruptions to care and research. Funding terminations. These are just some of the things many
Since the earliest days of the HIV epidemic, advances in HIV medicine have profoundly transformed the health care system itself,
Recent upheavals within the federal government and public health infrastructure are already casting a shadow over the lives of our
Cedric Sturdevant woke up with “a bit of depression” but made it to church, as he does every Sunday. In
Introduction As the general population of people with HIV continues to age, so accompanies the risk for polypharmacy (the use
President Donald Trump has a stated mission to “drain the swamp” or, in other words, to rid our society of
In the early months of this year, as the contours of the Trump Administration’s second term began to assert themselves
In my work as a therapist, I witness daily how my patients’ HIV diagnosis and trauma can intersect and compound
On Tuesday, April 1, the Trump Administration began sweeping cuts to the U.S. Department of Health and Human Services (HHS),
Gilead Sciences, Inc. (Nasdaq: GILD) announced [on June 18, 2025] that the U.S. Food and Drug Administration (FDA) has approved
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce
The spring issue of HIV Specialist is focused on the topic of syndemics and specific syndemic connections with HIV. “Syndemic”
As part of our ongoing effort to support the next generation of HIV care professionals, the American Academy of HIV
Featured Literature Preexposure Prophylaxis for HIV: Updated Recommendations from the 2024 International Antiviral Society-USA Panel. Available at: https://www.iasusa.org/2025/06/27/updated-recommendations-from-the-2024-international-antiviral-society-usa-panel/. Interim Guideline
On Monday, January 20, 2025, the Trump White House issued numerous executive orders, and several affect those in the LGBTQIA
On February 3, the American Academy of HIV Medicine (AAHIVM) announced the second year of the Dr. Dawn K. Smith
As health care services begin offering doxycycline to prevent bacterial sexually transmitted infections (STIs), real-world evidence demonstrates that the postexposure
Gilead Sciences, Inc. (Nasdaq: GILD) today [March 11] presented the first data from its ongoing Phase 1 study investigating two
Authors Angela C. Riley, PharmD, MPH, AAHIVE Director of Community and Provider Engagement American Academy of HIV Medicine Bernard A.
Featured Literature Chappell CA, Kiser JJ, Brooks KM, et al. Sofosbuvir/velpatasvir pharmacokinetics, safety, and efficacy in pregnant people with hepatitis
Abstract The United States continues to face a mismatch between demand for HIV prevention and care and the supply of
As Program Director of the Kaiser Permanente Northern California HIV Medicine Fellowship, I am delighted to share our experience in
In our Ryan White-funded clinics, we are nothing if not adaptable and efficient. As a pharmacist in a safety net
HIV care in the United States is one of medicine’s most impressive success stories. In the darkest days of the
When I recently spoke with Dr. Amanda Allmacher, AAHIVE, about the future of the HIV workforce, our conversation quickly became
I’d like to welcome you to the first fully digital issue of the quarterly HIV Specialist. This all-new digital format
The U.S. Food and Drug Administration (FDA) has approved Tivicay PD tablets for oral suspension (dolutegravir) to treat HIV infection
Emerging adults who participated in workshops combining evidence-based interventions and traditional practices reported reduced cannabis, alcohol use, and anxiety. A
On August 11, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a much-anticipated final rule prohibiting federal Medicaid or Children’s
May 6, 2026 — The Trevor Project, the leading suicide prevention and crisis intervention organization for LGBTQ+ young people, released The 2025
Featured Literature McCrary LM, Curtis MR, Kelly JC, et al. Real-world experience of hepatitis C treatment with glecaprevir-pibrentasvir during pregnancy.
The future HIV clinic is not fully automated. It is not fully virtual. And it is not fully digital. It is digitally augmented.
Geographical disparities in HIV-related health care access and treatment adherence exist in the United States, with nearly 50 percent of new HIV infections and lower rates of pre-exposure prophylaxis (PrEP) utilization in the South.
Generative artificial intelligence (AI) is already part of how our students learn, study, and communicate. The question is no longer whether students will use it. The question is whether we, as educators, will guide its use in a way that strengthens clinical reasoning, protects patient safety, and preserves academic integrity.
It’s the rare policy question that unites Republican Gov. Ron DeSantis of Florida and the Democratic-led Maryland government against President Donald Trump and Gov. Gavin Newsom of California: How should health insurers use AI?
From chatbots answering patient questions to the rollout of AI tools used to support patient management, the artificial intelligence (AI) era is upon us now and it’s imperative to fully understand the promise – and pitfalls – of this new technology to help guide patient care and counseling.
The American Academy of HIV Medicine (AAHIVM) announces the third year of the Dr. Dawn K. Smith HIV Prevention Clinical Fellowship, which is funded by a grant through ViiV Healthcare.
A study funded by the National Institutes of Health (NIH) reduced new HIV cases by 70 percent in rural Kenya and Uganda by pairing digital tools with tailored HIV services delivered by community health workers and clinicians.
ViiV Healthcare announced week 96 and end-of-study results from the phase I/II IMPAACT 2017 (MOCHA) study, the first trial to evaluate a complete injectable long-acting treatment regimen in adolescents living with HIV.
The Health Resources and Services Administration (HRSA) released new data, marking a record-breaking 91.4 percent of patients receiving HIV medical care through the Ryan White HIV/AIDS Program were virally suppressed, significantly exceeding the national viral suppression rate.
On April 14, the American Academy of HIV Medicine (AAHIMV), along with other members of the Emergency HIV Clinical Response Task Force (the Task Force), released updated data quantifying the scope and nature of HIV service disruptions resulting from harmful policy and funding decisions. The findings from the survey lay bare the dangerous barriers to care facing patients and underscore significant strain in the HIV response in the United States.
Long-acting injectable antiretroviral therapy (LA-ART) using cabotegravir and rilpivirine is an emerging strategy to address adherence challenges among people with HIV.
Featured Literature Koethe JR, Lake JE, Kantor A, et al. A 48-week, Randomized Controlled Trial of Doravirine for Individuals with
For decades, HIV has been linked in the public perception with weight loss and wasting. The image of a “slimming
Abstract Despite being a population with a high incidence of human immunodeficiency virus (HIV), adolescents and young adults have had